Buprenorphine And Naloxone Film, Soluble
Product Images NDC 43598-582

10 FDA label images from Dr.reddys Laboratories Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 43598-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Dr.Reddy's Laboratories Inc. The label indicates Rx only, contains 30 pouches each with 1 sublingual film, with instructions and warnings for use. The label shows barcodes, lot, and expiration areas, and notes the film is for buccal and sublingual routes.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
Packaging label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Dr. Reddys Laboratories Inc. The label shows a box containing 30 pouches, each with one buccal/sublingual film. It includes instructions and warnings, the NDC 43598-582-30, and emphasizes Rx only status.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
An illustration showing a pair of hands folding a small, rectangular paper or leaflet with densely printed text on it. The text is mostly illegible. The image likely demonstrates how to handle or fold product information or instructions related to the drug Buprenorphine and Naloxone soluble film.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
An instructional illustration showing hands manipulating a small, rectangular soluble film strip labeled with drug information text and a barcode. The left panel shows a person carefully peeling or stretching the film strip, while the right panel shows scissors cutting the strip at a perforated section. The instructions appear to demonstrate proper handling or dosing of the film form of Buprenorphine and Naloxone.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
An illustration showing a mouth with an open view of the tongue, demonstrating the placement of a soluble buccal or sublingual film on the lower gum or inner cheek. The image is related to the administration of Buprenorphine and Naloxone film, soluble dosage form for buccal or sublingual use.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
Instructional illustration showing the placement of a soluble buccal or sublingual film inside the mouth. Left panel depicts a hand positioning the film on the inside of the lower lip or cheek, while the right panel shows the film fully applied to the buccal mucosa. The image relates to the administration of buprenorphine and naloxone soluble film.*
FDA Label Image

Pouch1 (Pouch1)

Pouch1 (Pouch1)
Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Dr.Reddy's Laboratories Inc. The label is for 1 sublingual film with prescription only status, featuring storage and safety information including warnings for accidental ingestion by children and instructions not to cut, chew, or swallow the film. The label includes the NDC 43598-579-01, a barcode, and usage instructions.*
FDA Label Image

Pouch2 (Pouch2)

Pouch2 (Pouch2)
Label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Dr. Reddy's Laboratories Inc. The label shows one sublingual film dosage form for buccal or sublingual administration. It includes safety warnings about accidental ingestion by children and cautions not to cut, chew, or swallow the film. The label prominently shows the product name, strength, NDC (43598-582-01), and Rx only status.*
FDA Label Image

Structure1 (Structure1)

Structure1 (Structure1)
Chemical structure of buprenorphine hydrochloride, showing the molecular formula C29H41NO4·HCl and molecular weight 504.10. The diagram depicts the arrangement of rings, bonds, and functional groups characteristic of the compound.*
FDA Label Image

Structure2 (Structure2)

Structure2 (Structure2)
Chemical structure diagram of Buprenorphine hydrochloride dihydrate, showing its molecular formula C19H21NO4•HCl•2H2O and molecular weight 399.87.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.